These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38278100)

  • 21. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model.
    Yousefi Avarvand A; Meshkat Z; Khademi F; Tafaghodi M
    Microb Pathog; 2021 May; 154():104842. PubMed ID: 33762199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel multistage antigens ERA005f confer protection against
    Fan X; Zhao X; Wang R; Li M; Luan X; Wang R; Wan K; Liu H
    Front Immunol; 2023; 14():1276887. PubMed ID: 38022539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
    Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
    Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for
    Hoseinpur R; Hasani A; Baradaran B; Abdolalizadeh J; Amini Y; Salehi R; Samadi Kafil H; Azizian K; Memar MY; Gholizadeh P; Hasani A
    J Biomater Appl; 2022 Jul; 37(1):40-47. PubMed ID: 35430919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.
    Rodo MJ; Rozot V; Nemes E; Dintwe O; Hatherill M; Little F; Scriba TJ
    PLoS Pathog; 2019 Mar; 15(3):e1007643. PubMed ID: 30830940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
    Singh S; Saraav I; Sharma S
    Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit.
    Yadav J; Phogat S; Chaudhary D; Jaiwal R; Jaiwal PK
    Biotechnol Lett; 2023 Jun; 45(5-6):703-717. PubMed ID: 37074553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
    Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
    J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection.
    Lin PL; Dietrich J; Tan E; Abalos RM; Burgos J; Bigbee C; Bigbee M; Milk L; Gideon HP; Rodgers M; Cochran C; Guinn KM; Sherman DR; Klein E; Janssen C; Flynn JL; Andersen P
    J Clin Invest; 2012 Jan; 122(1):303-14. PubMed ID: 22133873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
    Villarreal DO; Siefert RJ; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
    Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
    Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with peptide-based immunogenic complex enhances BCG vaccine efficacy in a murine model of tuberculosis.
    Kumar S; Bhaskar A; Patnaik G; Sharma C; Singh DK; Kaushik SR; Chaturvedi S; Das G; Dwivedi VP
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33444288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the immunogenicity of Rv2201-519: A T-cell epitope-based antigen derived from Mycobacterium tuberculosis AsnB with implications for tuberculosis infection detection and vaccine development.
    Luan X; Fan X; Li G; Li M; Li N; Yan Y; Zhao X; Liu H; Wan K
    Int Immunopharmacol; 2024 Mar; 129():111542. PubMed ID: 38342063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice.
    Soleimanpour S; Farsiani H; Mosavat A; Ghazvini K; Eydgahi MR; Sankian M; Sadeghian H; Meshkat Z; Rezaee SA
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10467-80. PubMed ID: 26373723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis.
    Bertholet S; Ireton GC; Ordway DJ; Windish HP; Pine SO; Kahn M; Phan T; Orme IM; Vedvick TS; Baldwin SL; Coler RN; Reed SG
    Sci Transl Med; 2010 Oct; 2(53):53ra74. PubMed ID: 20944089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.